Assessment of Serum Biomarkers associated with Vedolizumab Therapy Response in Inflammatory Bowel Disease.

被引：0
|
作者：
O'Connell, J. [1 ]
Argue, R. [1 ]
Dunne, M. [2 ]
O'Connell, F. [2 ]
Breslin, N. [3 ]
Cullen, G. [4 ]
Doherty, G. [4 ]
Dunne, C. [1 ]
Hartery, K. [1 ]
Ismail, M. S. [3 ]
MacCarthy, F. [1 ]
McDonagh, P. [1 ]
McKiernan, S. [1 ]
McNamara, D. [3 ]
Mulcahy, H. [1 ,4 ]
O'Connor, A. [3 ]
Ryan, B. [3 ]
Sheridan, J. [4 ]
O'Sullivan, J. [2 ]
Kevans, D. [1 ]
机构：
[1] St James Hosp, Gastroenterol, Dublin, Ireland
[2] Trinity Coll Dublin, Trinity Translat Med Inst, Surg, Dublin, Ireland
[3] Tallaght Univ Hosp, Gastroenterol, Dublin, Ireland
[4] St Vincents Univ Hosp, Gastroenterol, Dublin, Ireland
来源：
JOURNAL OF CROHNS & COLITIS | 2024年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P041
引用
收藏
页码：I299 / I299
页数：1
相关论文
共 50 条
  • [41] Complications during cyclosporine therapy for inflammatory bowel disease.
    Stein, R
    Cohen, R
    Hanauer, S
    GASTROENTEROLOGY, 1997, 112 (04) : A1096 - A1096
  • [42] HIGHER VEDOLIZUMAB TROUGH LEVELS ASSOCIATED WITH REMISSION IN INFLAMMATORY BOWEL DISEASE (IBD) DURING MAINTENANCE THERAPY
    Ungaro, Ryan C.
    Jossen, Jacqueline
    Phan, Becky L.
    Chefitz, Ezra
    Sehgal, Priya
    Jain, Anjali
    Naik, Snehal
    Dubinsky, Marla
    GASTROENTEROLOGY, 2017, 152 (05) : S384 - S385
  • [43] Biomarkers of bone metabolisms, gut barrier and immune response are associated with the form, activity and therapy of inflammatory bowel disease
    Coufal, Stepan
    Bajer, Lukas
    Drastich, Pavel
    Zakostelska, Zuzana Jiraskova
    Kostovcikova, Klara
    Hogenova, Helena Tlaskalova
    Kverka, Miloslav
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2021, 51 : 320 - 320
  • [44] Early vedolizumab trough levels are not associated with a short-term response in patients with inflammatory bowel disease
    Pudilova, K.
    Kolar, M.
    Duricova, D.
    Malickova, K.
    Hruba, V.
    Machkova, N.
    Vanickova, R.
    Mitrova, K.
    Lukas, M.
    Vasatko, M.
    Lukas, M.
    Bortlik, M.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S356 - S356
  • [45] EARLY VEDOLIZUMAB TROUGH LEVELS ARE NOT ASSOCIATED WITH A SHORT-TERM RESPONSE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Pudilova, Karolina
    Duricova, Dana
    Kolar, Martin
    Malickova, Karin
    Hruba, Veronika
    Machkova, Nadezda
    Vanickova, Radka
    Mitrova, Katarina
    Lukas, Martin
    Vasatko, Martin
    Lukas, Milan
    Bortlik, Martin
    GASTROENTEROLOGY, 2019, 156 (06) : S877 - S877
  • [46] Colonic Tissue Expression of MAdCAM-1 Is Associated With Response to Vedolizumab in Patients With Inflammatory Bowel Disease
    Reddy, Nikhil
    Klein, Jeremy A.
    Deng, Zifeng
    Thomas, Nikita
    Micic, Dejan
    Rubin, David T.
    Cohen, Russell D.
    Dalal, Sushila
    Bissonnette, Marc
    Weber, Christopher
    Pekow, Joel
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S847 - S847
  • [47] Serum Biomarkers Are Associated With Endoscopic and Clinical Outcomes in Crohn's Disease Patients Receiving Vedolizumab Therapy
    Holmer, Ariela
    Battat, Robert
    Dulai, Parambir
    Vande Casteele, Niels
    Neill, Jennifer
    Le, Helen N.
    Miralles, Ara
    Jain, Anjali
    Hester, Kelly
    Singh, Siddharth
    Rivera-Nieves, Jesus
    Sandborn, William J.
    Boland, Brigid
    Nghia Nguyen
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S480 - S481
  • [48] Serum acute phase proteins in feline inflammatory bowel disease.
    Jergens, A. E.
    Crandell, J. M.
    Morrison, J. A.
    Allenspach, K.
    Pressel, M. A.
    Miles, K. G.
    Burke, K. F.
    Suchodolski, J. S.
    Steiner, J. M.
    Evans, R.
    JOURNAL OF VETERINARY INTERNAL MEDICINE, 2007, 21 (03) : 612 - 612
  • [49] Vedolizumab Therapy With or Without an Immunosuppressant for the Therapy of Inflammatory Bowel Disease: A Single Center Experience
    Chilukuri, Prianka
    Xu, Huiping
    Bohm, Matthew
    Sagi, Sashivar
    Fischer, Monika
    GASTROENTEROLOGY, 2016, 150 (04) : S812 - S813
  • [50] Value of mucosal assessment and biomarkers in inflammatory bowel disease
    Stidham, Ryan W.
    Higgins, Peter D. R.
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2010, 4 (03) : 285 - 291
12345